Clinical Trials Logo
  1. Home
  2. Acute Coronary Syndrome
  3. NCT02099422
  4. Details
NCT02099422 Clinical Trial

Timing of Optimal Platelet Inhibition After Acute Coronary Syndrome

Acute Coronary Syndrome Clinical Trial

— TOPIC  

Official title:
The Randomized TOPIC Study : Timing of Optimal Platelet Inhibition After Acute Coronary Syndrome

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT02099422
Other study ID # APHM-011
Secondary ID 2013-A01168-37
Status Recruiting
Phase N/A
First received March 26, 2014
Last updated March 26, 2014
Start date January 2013
Est. completion date January 2016

Study information
Verified date March 2014
Source Hôpital de la Timone
Contact thomas cuisset, MD-PHD
Phone 33(0) 491385981
Email thomas.cuisset@ap-hm.fr
Is FDA regulated No
Health authority france : "ANSM"
Study type Observational

Clinical Trial Summary

Comparison of two antiplatelet strategies between months 1 and 12 after coronary stenting for ACS. Efficiency and tolerance évaluation

Recruitment information / eligibility
Status Recruiting
Enrollment 500
Est. completion date January 2016
Est. primary completion date January 2015
Accepts healthy volunteers
Gender Both
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

- ACS and coronary stenting one month ago

Exclusion Criteria:

- age under 18 and pregnancy

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

Locations
Country Name City State
France CHU Timone hospital . Sc CARDIOLOGIE. Rue saint Pierre. Marseille

Sponsors (1)
Lead Sponsor Collaborator
Hôpital de la Timone

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary combined ischemic and hemorragic endpoint 12 months No
See also
  Status Clinical Trial Phase
Recruiting NCT06013813 - Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT05412927 - AngelMed Guardian® System PMA Post Approval Study
Completed NCT02750579 - Early or Delayed Revascularization for Intermediate and High-risk Non ST-elevation Acute Coronary Syndromes? N/A
Completed NCT04102410 - Assessing Force-velocity Profile: an Innovative Approach to Optimize Cardiac Rehabilitation in Coronary Patients N/A
Enrolling by invitation NCT03342131 - Serum Concentration of Wnt2 and Wnt4 in Patients With Acute Coronary Syndrome N/A
Recruiting NCT01218776 - International Survey of Acute Coronary Syndromes in Transitional Countries
Enrolling by invitation NCT04676100 - International CR Registry
Completed NCT03590535 - 5th Generation cTnT in ED ACS
Recruiting NCT05437900 - INSIGHTFUL-FFR Clinical Trial Phase 4
Completed NCT05551429 - Factors Related to Participation in Cardiac Rehabilitation in Patients With Acute Coronary Syndrome
Terminated NCT04316481 - IDE-ALERTS Continued Access Study N/A
Active, not recruiting NCT04475380 - Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
Not yet recruiting NCT04852146 - Electronic Feedback for Data Restitution and Valorization to the Emergency Teams in Aquitaine.
Active, not recruiting NCT02892903 - In the Management of Coronary Artery Disease, Does Routine Pressure Wire Assessment at the Time of Coronary Angiography Affect Management Strategy, Hospital Costs and Outcomes? N/A
Completed NCT04077229 - Piloting Text Messages to Promote Positive Affect and Physical Activity N/A
Completed NCT02944123 - Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR) Phase 3
Not yet recruiting NCT02871622 - BMX Alpha Registry: a Post-market Registry of the BioMatrix Alpha TM N/A
Active, not recruiting NCT02922140 - The Impact of Pharmaceutical Care Practice on Patients in Cardiac Rehabilitation Unit N/A
Completed NCT02673437 - Rivaroxaban ACS Specialist Cohort Event Monitoring Study